Myanmar news
Gavi Features
Press Releases
Myanmar introduces cervical cancer vaccine nationally, despite COVID-19 challenges
Around 450,000 girls aged 9-10 will receive the human papillomavirus (HPV) vaccine, which protects against the leading cause of cervical cancer. Myanmar currently has the second-highest incidence of cervical cancer in Southeast Asia.
Statements
Vaccineswork
Myanmar celebrates the launch of the HPV vaccine
Nearly half a million girls to be protected each year following the launch of the HPV, which will be provided with financial support from Gavi, the Vaccine Alliance. Here’s a closer look at the launch ceremony.
Top stories
Myanmar introduces cervical cancer vaccine nationally, despite COVID-19 challenges
Around 450,000 girls aged 9-10 will receive the human papillomavirus (HPV) vaccine, which protects against the leading cause of cervical cancer. Myanmar currently has the second-highest incidence of cervical cancer in Southeast Asia.